Highland Instruments
Braintree, US · Delaware corporation
Highland Instruments develops ESStim, a noninvasive brain stimulation technology intended to treat chronic pain, neurodegenerative diseases, and psychiatric disorders, currently limited to investigational use under US law. The company also holds intellectual property in artificial intelligence, imaging, neuromodulation, wearable sensors, and human movement kinematics.
Founders & leadership
LD
Laura DipietroChief Technology Officer
AH
Alex HerzlingerChief Business Officer
LL
Lynn LaneNamed on SEC filing
WE
William EdelmanNamed on SEC filing
TW
Timothy WagnerFounder/Chief Science Officer
Board
JM
John McDonoughChairman
Reported raises · per SEC filings
Form D private placements$750K disclosed across 1 round · 2021
▶$750KraisedFeb 2021 · 17 investors · Other Health CareRule 506(b)
▶$750KraisedFeb 2021 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lynn LaneExecutive Officer, Director
- William EdelmanExecutive Officer, Director
- Timothy WagnerExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $750K
- Minimum investment
- $5K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Highland Instruments do?
- Highland Instruments develops ESStim, a noninvasive brain stimulation technology intended to treat chronic pain, neurodegenerative diseases, and psychiatric disorders, currently limited to investigational use under US law. The company also holds intellectual property in artificial intelligence, imaging, neuromodulation, wearable sensors, and human movement kinematics.
- How much funding has Highland Instruments raised?
- Highland Instruments has disclosed $750K raised across 1 round.
- Where is Highland Instruments headquartered?
- Highland Instruments is headquartered in Braintree, US.